W5L1 thurs Cancer 2 Flashcards
Angiogenesis
-Tumors recruit blood vessels
-Signals from the tumor can cause nearby blood vessels to sprout new branches which invade the tissue.
-Once the tumor is vascularised its growth becomes exponential and it is able to metastasis.
How can tumor attract blood vessels
-As tumors grow, central cells become starved of oxygen. This condition is sensed by a protein called Hypoxia Inducible Factor 1a (HIF1a).
-At normal oxygen levels, HIF1a is degraded (due to another protein pVHL) but in hypoxic conditions it builds up and is able to activate transcription of Vascular Endothelial Growth Factor (VEGF).
-VEGF diffuses out and activates the VEGF Receptor on nearby endothelial cells triggering the sprouting of new vessels
Initial stages of metastasis
-The metastasis of epithelial tumors begins with an epithelial mesenchymal transition (EMT).
-Cells lose their epithelial characteristics and become migratory. This allows them to invade the surrounding tissue and enter the vasculature.
-A process called intravasation.
Gene responsible for EMT: finding it
-4 cell line isolated from mammary tumor
-inject these cell back into a naive mice
- All cell line produce tumors but one did not metastasise. Further analysis by microarray
- Twist was found as the odd one out from the arry. Reducing twist level prevent metastasis
Role of TWIST
-Twist represses E-Casherin
-When cells undergo an EMT, they stop expressing epithelial genes like E-Cadherin and b-catenin and start expressing mesenchymal genes needed for migration like the intermediate filament protein, Vimentin.
Twist as a prognostic marker for cancer
-Twist is upregulated in many cancers and predicts poorer survival
e.g. Types of cancers include breast, ovarian, cervical, prostate, bladder, hepatocellular, gastric, colorectal, and Chronic Myeloid Leukemia.
Origin of TWIST discovery
During early Drosophila development, Twist is expressed in cells on the ventral side of the embryo.
-These cells are initially epithelial but Twist expression causes them to break free of their neighbours and become migratory. In twist mutants this process fails.
-TWIST is a conserved driver of EMT
E-Catherine and cancer
-E-Cadherin is a tumor suppressor
-Loss of E-Cadherin is a common feature of cancer cells
-Hereditary loss-of-function mutations in CDH1 (i.e. E-Cadherin) greatly increase risk of diffuse gastric cancer.
Circulating Tumor Cells
-The tumor cells that enter the blood stream are then called Circulating Tumor Cells or CTCs
-The formation of the secondary tumors (also called metastases) around the body involves CTCs leaving the blood vessel (a process called extravasation) to seed the new tumor.
-The growth of the secondary tumors is thought to involve a mesenchymal to epithelial transition (MET).
-Circulating tumor cells (CTCs) can also circulate as clusters, also called Circulating Tumor Microemboli (CTMs)
What is more dangerous? CTCs or CTMs Experiment
- inject mix of red and green tumor cells.
- look in the blood for CTCs (i.e. single colour) and CTMs (single colouror multi-coloured).
- Look at metastases. Are they single or multi-coloured.
> CTMs are much better at metastasisng but higher discovery of CTC in the bloods
The cell search system
-The CellSearch system is designed to detect Circulating Tumor Cells.
-Blood samples from a patient are submitted to the machine, it immunomagnetically sorts the cells, immunostains them, and then presents them for inspection
Principle of Cellsearch system
-anti-EpCam recognises the Epithelial Cell Adhesion Molecule which is strongly expressed in human adenocarcinoma cells
-anti-CD45-APC identifies leukocytes, (regarded as a contaminant)
-anti-CK-PE identifies intracellular cytokeratins 8, 18, and/or 19
Counting CTCs has prognostic value
- 430 metastatic colorectal cancer patients were analysed with the CellSearch® System before and during treatment.
- patients were classified into favourable (<3 CTC/ 7.5 mL) and unfavourable (≥3 CTC/7.5 mL) groups.
- favorable patients had longer survival time (18.5 v 9.4 months).
- Conversion of unfavorable to favorable at 3-5 weeks of treatment was associated with longer survival time (compared to patients with unfavorable CTCs at both time points) (11.0 v 3.7 months).
Cancer stem cell hypothesis
-like normal tissue, cancer is comprised of different cell type
-experiments show that typically only 1% of tumor cell can initiate a new tumor
-Think that there is a cancer stem cell that can under goes self-renewal and give rise to the many cell types
cancer heterogeneity and clonal evolution
-Cancer cells can be thought of as being in competition. If a cell acquires a mutation that makes it proliferate more quickly, for example, its progeny will become more prevalent in the tumor. —Thus a tumor is actually genetically heterogenous (i.e. made up of cells with different mutations) and this genetic makeup evolves over time.